HSA | FSA CARDS ARE NOW ACCEPTED

Understanding Your TNFSF11 (RANKL) Result and Bone Health

Osteoporosis is a condition where bones become weak and fragile because the normal balance between bone breakdown and bone formation is disrupted. The TNFSF11 gene produces a protein called RANKL that tells bone-resorbing cells to break down bone. Variations in TNFSF11 can change how much RANKL is produced or how it functions, which can influence bone mineral density (BMD) and fracture risk over time.

This report explains what the rs2277438 result can mean for bone health and gives practical, evidence-based strategies you can use to support strong bones. Genetics is only one part of the picture. Diet, activity, lifestyle, body composition, hormones, certain medications, and other genes also shape bone health. PlexusDx does not provide medical advice. Please consult your healthcare provider before making medical decisions, starting supplements, or changing treatment.

How TNFSF11 (RANKL) affects bone remodeling

Bone is a living tissue that is constantly remodeled. Osteoclasts remove old bone while osteoblasts build new bone. RANKL is a signal that encourages osteoclasts to break down bone. Higher RANKL signaling can tilt the balance toward increased bone resorption and lower BMD. Variants at rs2277438 have been associated with differences in BMD, so your genotype may indicate a small change in lifetime risk for weaker bones.

Everyday strategies to support bone strength

  • Dietary calcium: Aim for consistent calcium intake from food first. Good sources include dairy, fortified plant milks, canned salmon/sardines with bones, tofu made with calcium sulfate, leafy greens (collard greens, kale), and some legumes. Typical adult targets are 1,000 to 1,200 mg/day depending on age and sex; confirm target with your clinician.
  • Vitamin D: Important for calcium absorption and bone health. Obtain safe sun exposure when possible and consider a supplement if levels are low. Many adults need 600–2000 IU/day depending on blood level and risk factors; check 25(OH)D with your provider.
  • Protein: Adequate protein supports bone matrix. Include quality protein across meals from lean meats, fish, dairy, legumes, or plant sources.
  • Weight-bearing and resistance exercise: Activities like walking, jogging, stair climbing, hiking, dancing, tennis and strength training help stimulate bone formation. Aim for a combination of at least 150 minutes/week of moderate activity plus 2–3 resistance sessions weekly.
  • Avoid smoking and limit alcohol: Smoking is linked to lower BMD and higher fracture risk. Limit alcohol to moderate levels — excessive use harms bone.
  • Maintain healthy body weight: Very low body weight increases fracture risk; extreme weight loss or eating disorders are major risk factors.
  • Fall prevention: Reduce fall risk through balance training (yoga, tai chi), home safety checks, vision care, and medication reviews with your clinician.

Supplements and tests to consider with your healthcare provider

  • Calcium supplement: If dietary intake is inadequate, a supplement can help you meet your target. Discuss dose and timing with your clinician.
  • Vitamin D testing: Check 25-hydroxyvitamin D level if you have risk factors for deficiency. Supplement to achieve an adequate blood level as advised by your clinician.
  • Bone density testing: A DEXA scan may be appropriate based on age, fracture history, family history of hip fracture, prolonged glucocorticoid use, or other risk factors. Discuss timing with your provider.
  • Medication review: Some medications affect bone health. Ask your clinician to review prescriptions and over-the-counter drugs for bone-related effects.

Genetic interpretations for rs2277438 (TNFSF11)

Two effect alleles — GG (higher genetic signal for lower BMD)

If your genotype is GG, you carry two copies of the effect allele. This result has been associated with lower bone mineral density in population studies and suggests a genetic predisposition toward greater bone resorption through altered RANKL signaling. It does not mean you will definitely develop osteoporosis, but it does indicate a higher relative risk compared with someone without this variant.

Practical steps

  • Prioritize a calcium- and vitamin D-rich diet and discuss supplementation if needed.
  • Include regular weight-bearing and resistance exercise programs tailored to your fitness level.
  • Consider earlier or more frequent bone density screening with your clinician, especially if you have other risk factors (family history of fracture, low body weight, long-term glucocorticoid use, menopause, etc.).
  • Avoid smoking and limit alcohol intake to protect bone health.
  • Talk with your healthcare provider about additional strategies if you have a personal or family history of fractures.
One effect allele — AG (likely modestly lower BMD)

If your genotype is AG, you carry one copy of the effect allele. This genotype is associated with a likely modest reduction in bone mineral density compared with people who do not carry the effect allele. The impact on lifetime fracture risk is usually small but may be relevant when combined with other risk factors.

Practical steps

  • Ensure consistent calcium intake from food and consider supplementation if dietary sources are insufficient.
  • Optimize vitamin D status; test levels if recommended by your provider and supplement to target levels.
  • Regular weight-bearing activity and resistance training can help maintain or increase bone strength.
  • Monitor lifestyle risks: avoid smoking, limit alcohol, maintain a healthy weight, and engage in balance exercises to prevent falls.
  • Discuss with your clinician whether bone density testing or earlier monitoring is appropriate based on age and other risk factors.
No effect alleles — AA (typical BMD for TNFSF11 pathway)

If your genotype is AA, you carry two copies of the non-effect allele for rs2277438. This suggests you do not have the G variant associated with altered RANKL signaling at this location and are not at increased genetic risk for lower BMD through this specific TNFSF11 pathway. That does not eliminate risk from other genes or non-genetic factors.

Practical steps

  • Continue standard bone-healthy habits: adequate calcium and vitamin D, weight-bearing and resistance exercise, avoiding smoking, and limiting alcohol.
  • Follow age- and risk-based screening recommendations for bone density and fracture prevention.
  • If you have other risk factors (family history, previous fractures, certain medications, early menopause), talk to your clinician about personalized monitoring or interventions.

When to talk with your healthcare provider

  • If you have a personal history of fractures after age 50 or a family history of hip fracture.
  • If you have risk factors such as long-term steroid use, early menopause, low body weight, or chronic conditions that affect bone health.
  • Before starting any new supplements or medications for bone health.
  • If you are unsure about when to begin bone density screening or how often to repeat it.

Genetic results like the TNFSF11 rs2277438 genotype can help you understand one piece of your bone health profile. They do not provide a complete prediction. Lifestyle, nutrition, physical activity, and medical care play major roles in maintaining strong bones as you age. PlexusDx does not provide medical advice. Use this information to inform conversations with your healthcare provider, who can integrate these findings with your medical history, physical exam, and appropriate testing to create a personalized plan.